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Summary: Additional information and some modifications of an earlier published method ((1972) Z. Klin. Chem.
Klin. Biochem., 10, 502-508) for the assay of oestrogen receptor in human breast tumours are presented. The
correlation between the results obtained with this method and with the electrophoresis procedure of Wagner ((1972)
Hoppe Seyler's Z. Physiol. Chem., 353', 1235-1245) was found to be good. The use of glycerol stabilized calf uterus
extract for quality control is proposed. Various factors affecting the assay and the discrimination between receptor
positive and receptor negative are critically discussed.
Kritische Bewertung einer Methode zur Bestimmung von Oestrogenrezeptoren unter Benutzung von Aktivkohle
Zusammenfassung: Erweiterte Informationen und einige Änderungen einer früher publizierten Methode ((1972) Z.
Klin. Chem. Klin. Biochem., 70,502—508) zur Bestimmung des Oestrogen-Rezeptors in menschlichen Mammatumoren
werden beschrieben. Die Methode zeigt eine gute Korrelation mit Wagner's Methode ((1972) Hoppe-Seyler's Z. Phy-
siol. Chem., 353,1235—1245), welche die Elektrophorese benutzt. Die Anwendung von mit Glycerin stabilisierten
Extrakten von Kalbsuterus für die Qualitätskontrolle wird vorgeschlagen. Verschiedene Faktoren, welche die Bestim-
mung und die Festlegung der Grenzwerte beeinflussen, werden diskutiert.
Introduction
The in-vitro assay of oestrogen receptors in human breast
cancer tumour tissue is based on the binding of tritiated
oestradiol-17-0 by an extract from a tumour biopsy. There
are several methods for the separation and quantisation
of receptor-bound oestradiol. Of these, the electrophore-
tic procedure (1) and some charcoal procedures (2—8)
are the most widely used.
In 1972 we introduced a simple charcoal method. We have
since been confronted with a number of questions con-
cerning discrimination of "receptor^positive" from
"receptor-negative" tumours, routine control of the
assay, equivalence of the results obtained by the electrp-
phofetic method and by our charcoal method, etc. This
paper is an attempt to provide answers to these questions.
Materials
Tritium labeled oestradiol-17-0, labeled in the 6,7 posi-
tions with an activity of about 1,48 TB q/mrnolf (40 Ci/
mmol) was obtained from the Radiochemical Centre,
Amersham, England. Upjohn 11,100 or nafoxidine
(l-[2-[p-(3.4-dihydro-6-methoxy-2-phenyl-l-naphthyl)
phenoxy] -ethyl] pyrrolidine HC1) was a gift from the
Upjohn Company, Rijswijk, Holland. Charcoal was
obtained from British Drug Houses, England (cat.
No. 33032).
Biopsies from metastases were freed from fat as comple-
tely as possible and were stored within 15 minutes at
- 70 °C until assay.
Uteri obtained from calves were chilled in ice imme-
diately after slaughtering. Within two hours they were
freed from connective tissue, cut into pieces and stored
at - 70 °C.
Methods
Reagents (charcoal assay)
All reagents should be stored at 4 °C.
Tris buffers
Buffer A contains dipotassium ethylene dinitrilo tetraacetate
(1.5 mmol/1) and sodium azide (1 mmol/1) in Tris buffer
(10 mmol/1).
Buffer B contains sucrose (250 mmol/1) in buffer A.
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Dextran coated charcoal
Dissolve 50 mg Dextran 10 (Pharmacia) and 100 mg gelatine
in 100 ml buffer B by gently heating up to 60 °C. After cooling
500 mg charcoal is added. The mixture is kept at 4 °C and dis-
carded after 1 month.
Aliquot s should be taken while stirring.
Upjohn 11,100
Dissolve 5.0 mg in 100 ml ethanol analytical grade.
Labeled oestradiol solutions
Stock solution is diluted with ethanol to a concentration of
200 nmol/1 (stable for 3 months). Twenty fold dilution with
buffer B gives the working solution (10 nmol/1).
Preparation of extracts
Homogenization was done as recommended at the E.O.R.T.C.
workshop on September 29,1972 (9). The "microdismembra-
tor" (Braun, Melsungen, Germany) used for the pulverization
of the frozen tissue allows maximal extraction of the receptor
protein (10). The powdered tissue, still frozen, was dissolved
in about two volumes (by weight) of cold (4 °C) buffer A. The
mixture was spun at 2-4 °C for 60 minutes at 100,000 g (Spinco,
S.W., 50.1; 2 ml cellulose nitrate reduction tubes). Then, the
supernatant was filtered (Schleicher and Sch ll 589/2 SS) at
4 °C to remove the fatty layer on top. Oil-free scissors were
used to cut the filter paper to a diameter of 5 cm. Glass tubes
were used for keeping the homogenates. Assays were performed
immediately following the preparation of the filtered super-
natant.
Assays
The electrophoretic method
This method has been described fully by Wagner (1). Receptor
concentrations were related to tissue protein as proposed by
Wagner (1).
The charcoal method
The assay was performed according to reference 8. Several modi-
fications have since been introduced, so that it is necessary to
describe the whole procedure. As a control, the assay uses Up-
john 11,100 (nafoxidine) which specifically inhibits the binding
of oestradiol to the receptor. Receptor concentrations were
calculated in terms of Bequerels (s""1) per gram total protein.
Procedure
The procedure for the charcoal assay is outlined in table 1.
Quench correction is determined for each sample since values
may deviate significantly from the quenching by the counting
fluid (Instagel).
Calculation
counts/ min 4.2 Χ ΙΟ6 χ -—
protein (g/1) counting efficiency (
counts/mm is difference between the counts per minute "total
bound" and "Upjohn 11,100 bound".
The factor
4.2 Χ 106 2.1 X 20,000 X 100
efficiency (%)
2.1
20,000
100
efficiency (%)
J_
60
is derived from
efficiency (%)
: to calculate total radioactivity of the
mixture
; activity expressed per litre extract
: converts this to dpm
converts this to Bq (s"1)
Classification of receptor-negative tumours ·
For statistical evaluation at least 15 benign human tumours
should be assayed by the above technique. A sufficient number
of malignant tumours should be also assayed, to include at least
eight with apparently higher binding capacities than the benign.
The results from benign and inalignant tumours are expressed
graphically with the probability function 2n-l on the abcissa
2N
and Bq/g protein on the ordinate. The value of η is the ranking
order of the specimens with the lowest activity assigned the
value of 1 and Ν is equal to the total number of specimens. The
probability can be found from a table or by using a linear-probit
paper. For an example see reference 11. Connection of the in-
serted points produces two straight lines. The highest value
(Bq/g protein) of the benign tumour which lies on the straight
line is still considered to be receptor-negative (or borderline
value), but higher values are taken as receptor-positive.
Allowable variation between duplicates
Incubations with [3Hjoestradiol and Upjohn 11,100 were run
in duplicate. For different ranges the standard deviation was
calculated according to s. d. = \l ~ - (12), where d is the
ι 2ii
difference between duplicates, η = number of specimens (usually
about twenty). Coefficients of variation (C. V.) were calculated
according to C. V. = _ s' ' where χ is the mean of the
χ
values found within a given range. The result of the assay was
accepted only if the duplicates deviated from one another by
less than 3.2 X C. V. percent.
Tab. 1. Procedure for measurement of oestrogen receptor.
All oestradiol containing solutions and pipettings of oestradiol or Upjohn 11,100 should be stored in or performed with glass
ware. All handlings at 4 °C.
Total counts
Control charcoal 1
Control charcoal 2
Total bound
Upjohn 11,100 bo und
Upjohn
solution
Ιμΐ]
10
10
13H]-
oestra-
diol
solution
[Ml]
100
100
100
100
100
buffer
Β
[Ml]
400
400
400
400
400 mix
buffer
A
[Ml]
50
50
50
extract
[Ml]
50
50
mix
and
incubate
over-
night
char-
coal
[Ml]
500
500
500
500
buffer
Β
[Ml]
500
mix
count*)
[Ml]
500
500
500
500
500
*) After three intermittent shakings for 10 seconds every 3 minutes.
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Total protein
We use the biuret method with a reaction mixture of 0.05 ml
extract and 2 ml biuret reagent. CuSO4 is omitted from the
blanks.
Results
Conditions of incubation
The time course of the binding of oestradiol at 4 °C
under conditions as described in ref. (8) is shown in
figure 1.
Incubation can be restricted to 2 hours if one wishes
to speed up the performance of the assay. In ref. (8)
a ΙΟ-minute charcoal incubation at 4 °C was recom-
mended. The effects of intermittent shaking for 10
seconds at 3-minute intervals were compared with
those of continuous shaking. The result of the assay
was not affected by intermittent shaking even if con-
tact with charcoal was extended to 90 minutes. Con-
tinuous shaking, however, reduced the difference in net
radioactivity between the supernatants of the tubes
with and without nafoxidine. A 60-xninute period of
continuous shaking reduced receptor-bound oestradiol
by 20%.
Comparative studies
Thirty-seven tumours were simultaneously assayed for
receptor content by the electrophoretic method and
the charcoal method. To exclude heterogeneity, the
material to be studied was not split up until after homo-
genization and centrifugation. The results of the latter
method were plotted according to probit analysis
(fig. 2). Figure 2 shows two groups with different Gaus-
sian distribution curves: one group comprises all benign
tumours and the malignant tuiriours defined as receptor-
negative and the other group comprises the tumours
shown to be receptor-positive (8,11). Tumours found
positive by the electrophoretic method were plotted as
solid circles and those found to be receptor-negative as
open circles. This makes it possible to compare the two
L _L JL
Ο ω 02 Q3 0.4 Q5 OJ6 " 1.37
Oestrogen receptor quantity iMBq/g total protein]
Fig. 2. Probit analysis of oestrogen receptor quantities determined
by the charcoal technique described, in malignant (circles)
and benign (triangles) human breast tumours. The solid
circles represent tumours found to be receptor-positive by
the electro p h or es is technique; the open circles represent
tumours found to be receptor-negative by the electropho-
resis technique.
methods. A good correlation is evident in figure 2:
only one tumour appeared to be receptor-positive by the
electrophoretic method, but receptor-negative by the
charcoal method.
Routine control
The rapid destruction of the receptor during storage in
the tumour extract, even at low temperatures (13,14),
raises problems in routine control.
In the search of a receptor-containing solution which
could serve as a routine control test, results were ob-
tained with calf uterine extract in the presence of gly-
cerol. The underlying idea is that, as for enzymes,
glycerol might act as stabilizer for oestrogen receptors.
The tissue powder was dissolved in a cooled mixture of
Tris buffer und glycerol (volumes, 10 ml + 10 ml) and
the mixture was stored at — 20 °C after centrifugation.
At regular intervals the receptor content was assayed
by the charcoal method. The results (fig. 3) show that
5,000 j-
3,000 4
Ξ 1,000
4 6
Inkubation [h]
18
Fig. 1. Time course for the binding of [3HJoestxadiol to receptor
in an extract of a human malignant breast tumour.
1.0
L0.5
16
Time [d]
24 32
Fig. 3. Binding capacity of calf uterus extract in the presence of
glycerol (1 + 1 by volume). The vertical bars indicate
maximum and minimum results over six replicates.
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the glycerol-stabilized supernatant can be used as a
control for a period of about 3 weeks. More significant
loss of binding capacity was found if the mixture was
stored at 4 °C. Contrary to Ratajczak &Hahnel (15) we
found that addition of dithioerythritol (1 mmol/1) was
not effective in stabilizing the receptor-binding capacity
in calf uterus extract.
Discussion
Various conditions for incubation with oestrogens or
charcoal have been proposed (1—9, 16-19) varying
from 30 minutes to several hours at temperatures from
4 °C to 30 °C. However, most relevant reports present
no data on the time course. We found the broad binding
optimum at 4 °C, unlike to the binding found at higher
temperatures (3), to be of advantage for establishing the
assay conditions. In incubation with charcoal two pro-
cesses govern the resulting [3H]oestradiol content after
separation of the charcoal:
adsorption of unbound and loosely bound oestradipl,
and the removal of receptor-bound oestradiol. The latter
process is negligible at intermittent shaking for short
periods but significantly influences the result of the
assay if continuous shaking is applied. We therefore feel
that the recommendations of the E.O.R. T.C. workshop
(9), specifying continuous shaking for 90 minutes are
not meaningful.
The time needed to complete the first process depends
on the efficiency of the charcoal batch. Under our con-
ditions of incubation the decrease of radioactivity to a
constant level within the first minutes of charcoal treat-
ment is regarded as an indication of sufficient efficiency
of the charcoal batch. Occasionally, a large excess of sex
hormonale binding globulin may be present in the
tumour tested. In such cases a constant level is not
reached until after about 10 minutes. The period of
contact with the charcoal and the periods of shaking
should therefore be timed exactly.
It is now well established that patients suffering from
breast cancer with oestrogen receptor-positive metas-
tases have about 60 percent chance of benefitting
from hormonal therapy, additive or ablative (20). An
explanation for this phenomenon cannot be given. Even
more puzzling is the fact that some patients with oestro-
gen receptor-negative metastases do respond to hormonal
therapy1). In this respect the criteria for the classification
of a tumour in terms of its receptor content are of some
concern to various authors. Jensen et ai (22) retrospecti-
vely defined the cut-off level on the basis of the lowest
receptor content at which objective remissions were
obtained. This theoretically attractive approach has been
followed by several authors, but has some drawbacks for
the early introduction of a receptor assay in the routine
laboratory. Firstly, it requires a long period of clinical
experience with a sufficient number of patients showing
objective remission. Secondly, modifications to improve
the assay technique cannot be introduced during the
period of evaluation of the patients. This procedure is
even more complicated if different additive therapies
are applied. In this respect it should be noted that the
highest incidence of responding receptor-negatives seems
to occur in therapy with anti-oestrogens (20). In view
of the above-mentioned disadvantages it is evident that
the procedure to determine the cut-off level should be
one that makes it possible to introduce the assay within
a short time. We first introduced probit analysis of benign
and malignant tumours to establish the discriminating
line between receptor-positive and receptor-negative.
The results of our clinical studies have proved the correct-
ness of this approach (11) which allows introduction of
the receptor assay in the routine laboratory within a
short time. In these studies both the charcoal method
(with nafoxidine as competitive inhibitor) and the elec-
tröphoretic method were applied.
Previous clinical data seemed to indicate the equivalence
of both techniques as indicator for hormone responsive-
ness (11). A compilation of all clinical data we have so
far obtained (11,21) gives the figures shown in table 2.
The equivalence of both techniques is evident. The data
in figure 2 supply strong additional evidence that either
of the two techniques can be used for prediction of the
response to endocrine therapy. They also indicate that,
for this purpose, it is sufficient to express receptor con-
centrations in terms of total tumour protein, rather
than tissue protein.
The charcoal method described, using nafoxidine as
competitive inhibitor, is the simplest and therefore the
Tab. 2. Correlation between presence of oestrogen receptors
in 148 patients as determined by different techniques,
and response to hormonal therapy. All patients were
investigated and followed up according to the criteria
outlined in the E.O.R.T.C. Breast Cancer Group protocol
(23). In all tissue samples the presence of cancer tissue
was verified histologically.
No. of patients
*) In our opinion additional assay of other hormone receptors
may make it possible to select patients within the oestrogen
receptor-negative group who nevertheless respond to hor-
monal therapy. Preliminary results of androgen receptor
assays in premenopausal patients are very promising (21).
Technique
Charcoal
«r
Electrophoresis
Recep-
tor
+
-
+
—
Re- Not re- Total
spending spending
24 6 30
4 28 32
23 7 30
6 - 5 0 5 6
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most attractive method for the routine laboratory. This
method produces data for the therapeutic strategy
in breast cancer which are as reliable as those obtained
from other but more complicated techniques, e. g. the
electrophoretic method.
The use of glycerol-stabilized calf uterus extract is per-
haps not ideal, but it is certainly a practical solution
to the problem of quality control of oestrogen receptor
assays.
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Note added to proof:
Problems in analysis of charcoal method data by Scatchard
plot, leading in some cases to mis-classification have been
described fully by H. Braunsberg (1975), Europ. J. Cancer
77,499-507.
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